A concise synthesis of (±) and a total synthesis of (+)-epiquinamide

Tetrahedron Letters

Volumn 47, Issue 29, 2006, Pages 5017-5020

 

^a Amy)   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EPIQUINAMIDE; QUINOLIZIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DIASTEREOISOMER; DRUG SYNTHESIS; STEREOCHEMISTRY;

EID: 33744990855     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.05.092     Document Type: Article

References (28)

1. Fitch R.W., Garraffo H.M., Spande T.F., Yeh H.J.C., and Daly J.W. J. Nat. Prod. 66 (2003) 1345-1350
2. Wijdeven M.A., Botman P.M.M., Wijtmans R., Schoemaker H.E., Rutjes F.P.J.T., and Blaauw R.H. Org. Lett. 7 (2005) 4005-4007
3. Huang P.-Q., Guo Z.-Q., and Ruan Y.-P. Org. Lett. 8 (2006) 1435-1438
4. Sparatore A., Basilico N., Parapini S., Romeo S., Novelli F., Sparatore F., and Taramelli D. Bioorg. Med. Chem. 13 (2005) 5338-5345
5. Collicutt A.R., and Jones G. J. Chem. Soc. (1960) 4104-4105
6. Hadley M.S., King F.D., McRitche B., Turner D.M., and Wells E.A. J. Med. Chem. 28 (1985) 1843-1847
7. Takehisa K., Kenji K., and Shunichi Y. Chem. Pharm. Bull. 15 (1967) 337-344
8. McFarlane A.K., Thomas G., and Whiting A. J. Chem. Soc., Perkin Trans. 1 (1995) 2803-2808
9. Leonard N.J., Swann Jr. S., and Figueras Jr. J. J. Am. Chem. Soc. 74 (1952) 4620-4624
10. Clemo G.R., and Ramage G.R. J. Chem. Soc. (1931) 437-442
11. Denmark S.E., and Matsuhashi H. J. Org. Chem. 67 (2002) 3479-3486
12. Aaron H.S., Wicks G.E., and Rader C.P. J. Org. Chem. 29 (1964) 2248-2252
13. Aaron H.S., Wicks G.E., and Rader C.P. J. Org. Chem. 29 (1964) 2252-2256
14. Moehrle H., Karl C., and Scheidegger U. Tetrahedron 24 (1968) 6813-6824
15. Hassner A., Maurya R., Padwa A., and Bullock W.H. J. Org. Chem. 56 (1991) 2775-2781
16. Chang M.-Y., Hsu R.-T., Tseng T.-W., Sun P.-P., and Chang N.-C. Tetrahedron 60 (2004) 5545-5550
17. Drag M., Lataj R., Gumienna-Kontecka E., Kozlowski H., and Kafarski P. Tetrahedron: Asymmetry 14 (2003) 1837-1845
18. Aldehyde 13 was used immediately upon synthesis as it was found to decompose in 1-2 days even if stored at low temperatures.
19. Balboni G., Marastoni M., Merighi S., Borea, Pier A., and Tomatis R.E. J. Med. Chem. 35 (2000) 979-988
20. Thai D.L., Sapko M.T., Reiter C.T., Bierer D.E., and Perel J.M. J. Med. Chem. 41 (1998) 591-601
21. Portoghese P.S., Pazdernik T.L., Kuhn W.L., Hite G., and Shafier A. J. Med. Chem. 11 (1968) 12-15
22. Logue M.W., and Teng K. J. Org. Chem. 47 (1982) 2549-2553
23. Ridgway B.H., and Woerpel K.A. J. Org. Chem. 63 (1998) 458-460
24. Gruza H., Kiciak K., Krasinski A., and Jurczak J. Tetrahedron: Asymmetry 8 (1997) 2627-2631
25. syn-1-N-Boc-2-Alcohols of this form commonly cyclise to form oxazolidinones, for examples, see:. Beak P., and Lee W. J. Org. Chem. 55 (1990) 2578-2580
26. +) 310.18385, found 310.18412.
27. We later were to discover that if at any time before the Boc group is removed and quinolizidine ring formation is complete that this hydroxyl group was converted to a mesylate then oxazolidinone formation is the predominant reaction, thus necessitating the protection of the hydroxyl group until that stage.
28. 1,2